Susquehanna International Group’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Buy |
482,728
+340,109
| +238% | +$840K | ﹤0.01% | 2981 |
|
|
2025
Q1 | $284K | Buy |
142,619
+105,567
| +285% | +$210K | ﹤0.01% | 5081 |
|
|
2024
Q4 | $108K | Sell |
37,052
-78,002
| -68% | -$228K | ﹤0.01% | 5659 |
|
|
2024
Q3 | $445K | Buy |
115,054
+9,162
| +9% | +$35.5K | ﹤0.01% | 3820 |
|
|
2024
Q2 | $544K | Buy |
105,892
+84,580
| +397% | +$435K | ﹤0.01% | 3403 |
|
|
2024
Q1 | $149K | Sell |
21,312
-25,273
| -54% | -$177K | ﹤0.01% | 4834 |
|
|
2023
Q4 | $413K | Buy |
+46,585
| New | +$413K | ﹤0.01% | 4115 |
|
|
2023
Q3 | – | Sell |
-12,254
| Closed | -$180K | – | 6172 |
|
|
2023
Q2 | $180K | Buy |
+12,254
| New | +$180K | ﹤0.01% | 4708 |
|